ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION

Lymphotoxin-α (LTA) is a major pro-inflammatory cytokine produced at the early stages of vascular inflammation, taking part in the formation of arterial atherosclerosis and development of coronary heart disease. Functional changes in the gene encoding LTA production may influence the development of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. A. Shmidt, S. A. Berns, I. I. Zhidkova, O. A. Makeeva, I. A. Goncharova, O. A. Nagirnyak, A. V. Klimenkova, M. N. Litvinova, O. L. Barbarash
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2018
Materias:
Acceso en línea:https://doaj.org/article/14d34ba953ae485fa3907ef9d3a21dfb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:14d34ba953ae485fa3907ef9d3a21dfb
record_format dspace
spelling oai:doaj.org-article:14d34ba953ae485fa3907ef9d3a21dfb2021-11-18T08:03:47ZASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION1563-06252313-741X10.15789/1563-0625-2018-1-73-84https://doaj.org/article/14d34ba953ae485fa3907ef9d3a21dfb2018-01-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1434https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XLymphotoxin-α (LTA) is a major pro-inflammatory cytokine produced at the early stages of vascular inflammation, taking part in the formation of arterial atherosclerosis and development of coronary heart disease. Functional changes in the gene encoding LTA production may influence the development of coronary heart disease with unfavorable progression. However, studies for associations between rs1041981 (C-804A) LTA gene variant and development of acute cerebrovascular accidents, myocardial infarction, and severity of coronary atherosclerosis have yielded contradictory results. The purpose of our study was to investigate an association of rs1041981 gene LTA with risk of adverse events within five years of follow-up in the patients with acute coronary syndrome without ST elevation ST (nonST-ACS). 178 patients with nonST-ACS from the Kemerovo Cardiology Center Registry were included into the study. Genotyping of rs1041981 site variable LTA gene was performed by TaqMan technique using an “iCycler iQ” device (BIO-RAD, USA). Results: we have found that the A allele and A/A genotype polymorphism in LTA gene (rs1041981) have been associated with development of adverse cardiovascular events over five years of observation (respective p levels were 0.02 and 0.036). In patients with A/A genotype, the rs1041981 polymorphism in LTA gene was associated with 3.8-fold increase in adverse cardiovascular events, compared to patients having A/C or C/C genotype. Carriage of A allele in LTA gene (rs1041981) doubles the risk of adverse cardiovascular events in patients with nonST-ACS at long observation terms. By means of Kaplan-Meier method, we have determined that survival to the first endpoint occurred more often in carriers of the genotype A/A of LTA gene (rs1041981). The A/A genotype of LTA gene (rs1041981) proved to be more significant (p = 0.016) for development of adverse outcomes, when combining the patients with A/C and C/C genotypes. One may draw a conclusion that A allele and A/A genotype of rs1041981 LTA polymorphism is associated with development of adverse cardiovascular events during the five-year period following the index event in patients with nonST-ACS.E. A. ShmidtS. A. BernsI. I. ZhidkovaO. A. MakeevaI. A. GoncharovaO. A. NagirnyakA. V. KlimenkovaM. N. LitvinovaO. L. BarbarashSPb RAACIarticlefive-year prognosisnonst-acsadverse eventsvariable gene sitesrs1041981 gene ltaImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 20, Iss 1, Pp 73-84 (2018)
institution DOAJ
collection DOAJ
language RU
topic five-year prognosis
nonst-acs
adverse events
variable gene sites
rs1041981 gene lta
Immunologic diseases. Allergy
RC581-607
spellingShingle five-year prognosis
nonst-acs
adverse events
variable gene sites
rs1041981 gene lta
Immunologic diseases. Allergy
RC581-607
E. A. Shmidt
S. A. Berns
I. I. Zhidkova
O. A. Makeeva
I. A. Goncharova
O. A. Nagirnyak
A. V. Klimenkova
M. N. Litvinova
O. L. Barbarash
ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
description Lymphotoxin-α (LTA) is a major pro-inflammatory cytokine produced at the early stages of vascular inflammation, taking part in the formation of arterial atherosclerosis and development of coronary heart disease. Functional changes in the gene encoding LTA production may influence the development of coronary heart disease with unfavorable progression. However, studies for associations between rs1041981 (C-804A) LTA gene variant and development of acute cerebrovascular accidents, myocardial infarction, and severity of coronary atherosclerosis have yielded contradictory results. The purpose of our study was to investigate an association of rs1041981 gene LTA with risk of adverse events within five years of follow-up in the patients with acute coronary syndrome without ST elevation ST (nonST-ACS). 178 patients with nonST-ACS from the Kemerovo Cardiology Center Registry were included into the study. Genotyping of rs1041981 site variable LTA gene was performed by TaqMan technique using an “iCycler iQ” device (BIO-RAD, USA). Results: we have found that the A allele and A/A genotype polymorphism in LTA gene (rs1041981) have been associated with development of adverse cardiovascular events over five years of observation (respective p levels were 0.02 and 0.036). In patients with A/A genotype, the rs1041981 polymorphism in LTA gene was associated with 3.8-fold increase in adverse cardiovascular events, compared to patients having A/C or C/C genotype. Carriage of A allele in LTA gene (rs1041981) doubles the risk of adverse cardiovascular events in patients with nonST-ACS at long observation terms. By means of Kaplan-Meier method, we have determined that survival to the first endpoint occurred more often in carriers of the genotype A/A of LTA gene (rs1041981). The A/A genotype of LTA gene (rs1041981) proved to be more significant (p = 0.016) for development of adverse outcomes, when combining the patients with A/C and C/C genotypes. One may draw a conclusion that A allele and A/A genotype of rs1041981 LTA polymorphism is associated with development of adverse cardiovascular events during the five-year period following the index event in patients with nonST-ACS.
format article
author E. A. Shmidt
S. A. Berns
I. I. Zhidkova
O. A. Makeeva
I. A. Goncharova
O. A. Nagirnyak
A. V. Klimenkova
M. N. Litvinova
O. L. Barbarash
author_facet E. A. Shmidt
S. A. Berns
I. I. Zhidkova
O. A. Makeeva
I. A. Goncharova
O. A. Nagirnyak
A. V. Klimenkova
M. N. Litvinova
O. L. Barbarash
author_sort E. A. Shmidt
title ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
title_short ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
title_full ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
title_fullStr ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
title_full_unstemmed ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
title_sort association of a lymphotoxin-α variable site rs1041981 with development of long-term unfavorable outcomes in patients with acute coronary syndrome without st-segment elevation
publisher SPb RAACI
publishDate 2018
url https://doaj.org/article/14d34ba953ae485fa3907ef9d3a21dfb
work_keys_str_mv AT eashmidt associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT saberns associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT iizhidkova associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT oamakeeva associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT iagoncharova associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT oanagirnyak associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT avklimenkova associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT mnlitvinova associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
AT olbarbarash associationofalymphotoxinavariablesiters1041981withdevelopmentoflongtermunfavorableoutcomesinpatientswithacutecoronarysyndromewithoutstsegmentelevation
_version_ 1718422334392500224